Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcome

Psycho-Oncology, 04/24/2012

Among US participants familiar with their hereditary melanoma risk through prior epidemiological research participation, CDKN2A/p16 genetic testing provides multiple perceived benefits to both carriers and noncarriers without inducing distress in general or worry about melanoma or pancreatic cancer.

Print Article Summary Cat 2 CME Report